Brief: Cullinan Oncology Q1 adjusted net loss USD 58.1 million
11/05/2023 21:15
May 11 (Reuters) - Cullinan Oncology Q1 cash & investments USD 503.5 million. * Q1 adjusted net income USD -58.1 million
CGEM — Cullinan Therapeutics News Story
0.000.00%
Last trade - 00:00- $960.17m
- $625.63m